Biodistribution of Zr-89-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast Cancer

E.C. Dijkers, T.H.O. Munnink, J.G. Kosterink, A.H. Brouwers, P.L. de Jager, J.R. de Jong, G.A.M.S. van Dongen, C.P. Schroder, M.N. Lub-de Hooge, E.G.E. de Vries

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)586-592
JournalClinical Pharmacology & Therapeutics
Volume87
Issue number5
DOIs
Publication statusPublished - 2010

Cite this

Dijkers, E. C., Munnink, T. H. O., Kosterink, J. G., Brouwers, A. H., de Jager, P. L., de Jong, J. R., ... de Vries, E. G. E. (2010). Biodistribution of Zr-89-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast Cancer. Clinical Pharmacology & Therapeutics, 87(5), 586-592. https://doi.org/10.1038/clpt.2010.12
Dijkers, E.C. ; Munnink, T.H.O. ; Kosterink, J.G. ; Brouwers, A.H. ; de Jager, P.L. ; de Jong, J.R. ; van Dongen, G.A.M.S. ; Schroder, C.P. ; Lub-de Hooge, M.N. ; de Vries, E.G.E. / Biodistribution of Zr-89-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast Cancer. In: Clinical Pharmacology & Therapeutics. 2010 ; Vol. 87, No. 5. pp. 586-592.
@article{82f058e3d37e43e8a1220454df1d1ff1,
title = "Biodistribution of Zr-89-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast Cancer",
author = "E.C. Dijkers and T.H.O. Munnink and J.G. Kosterink and A.H. Brouwers and {de Jager}, P.L. and {de Jong}, J.R. and {van Dongen}, G.A.M.S. and C.P. Schroder and {Lub-de Hooge}, M.N. and {de Vries}, E.G.E.",
year = "2010",
doi = "10.1038/clpt.2010.12",
language = "Undefined/Unknown",
volume = "87",
pages = "586--592",
journal = "Clinical Pharmacology & Therapeutics",
issn = "0009-9236",
publisher = "Wiley-Blackwell",
number = "5",

}

Dijkers, EC, Munnink, THO, Kosterink, JG, Brouwers, AH, de Jager, PL, de Jong, JR, van Dongen, GAMS, Schroder, CP, Lub-de Hooge, MN & de Vries, EGE 2010, 'Biodistribution of Zr-89-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast Cancer' Clinical Pharmacology & Therapeutics, vol. 87, no. 5, pp. 586-592. https://doi.org/10.1038/clpt.2010.12

Biodistribution of Zr-89-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast Cancer. / Dijkers, E.C.; Munnink, T.H.O.; Kosterink, J.G.; Brouwers, A.H.; de Jager, P.L.; de Jong, J.R.; van Dongen, G.A.M.S.; Schroder, C.P.; Lub-de Hooge, M.N.; de Vries, E.G.E.

In: Clinical Pharmacology & Therapeutics, Vol. 87, No. 5, 2010, p. 586-592.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Biodistribution of Zr-89-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast Cancer

AU - Dijkers, E.C.

AU - Munnink, T.H.O.

AU - Kosterink, J.G.

AU - Brouwers, A.H.

AU - de Jager, P.L.

AU - de Jong, J.R.

AU - van Dongen, G.A.M.S.

AU - Schroder, C.P.

AU - Lub-de Hooge, M.N.

AU - de Vries, E.G.E.

PY - 2010

Y1 - 2010

U2 - 10.1038/clpt.2010.12

DO - 10.1038/clpt.2010.12

M3 - Article

VL - 87

SP - 586

EP - 592

JO - Clinical Pharmacology & Therapeutics

JF - Clinical Pharmacology & Therapeutics

SN - 0009-9236

IS - 5

ER -